Director, DP Workstream Leader – Small Molecule Parenteral (LAIs and Oligos)
This role involves leading late-stage drug product development for sterile long-acting injectables and oligonucleotides, overseeing formulation, process development, and technology transfer across clinical and commercial phases. The position acts as a strategic bridge between CMC project teams and functional execution, ensuring regulatory robustness, supply readiness, and integrated solutions through cross-functional leadership. It emphasizes scientific excellence, risk mitigation, and patient-focused innovation within a hybrid working model.